How Pharmaceutical Companies Manipulate Patents to Extend Monopolies and Increase Drug Prices

Pharmaceutical Business Model and Patent Manipulation

• 💡 Pharmaceutical companies operate on a financialized business model aimed at maximizing revenue at all costs, often leading to billions in profits.
• 🎯 The current patent system allows companies to extend their patent monopolies beyond the initial expiration date through incremental tweaks and follow-up patents.
• 📈 This practice extends patent life from the standard 14 years to 16, 17, 18, 19, or even 20+ years, allowing them to maintain artificially elevated prices.

Case Study: Eliquis and GLP-1 Drugs

• 💊 The drug Eliquis, used to prevent blood clots, had its patent life extended by over a decade through five follow-up patents, potentially generating over $50 billion in revenue for Bristol Myers Squibb and Pfizer.
• 🌍 In Europe, generics for Eliquis entered the market in 2022, while in the US, extended exclusivity means higher prices for much longer.
• 💰 Similarly, GLP-1 drugs like those from Novo Nordisk are projected to generate $166 billion due to patent term extensions alone.

The Role of Patents and Shareholder Value

• ⚖️ The patent system, intended to incentivize R&D, is being used by pharmaceutical companies to extend monopolies and increase prices, often to please shareholders and Wall Street.
• 🔬 While patents are meant to incentivize R&D, reports show companies like Novo Nordisk spend more on share buybacks than on research and development.
• 🏦 A significant portion of drug research originates from government funding (e.g., NIH), with pharmaceutical companies primarily commercializing these discoveries rather than inventing them.

Public Awareness and Advocacy

• 🗣️ Public anger over high drug prices is growing, with a significant majority of Americans believing big pharma's profits are a major reason for high prescription drug costs.
• 🏛️ Citizens are encouraged to write to their representatives to express concern about how patent monopolies lead to higher drug prices.
• 📢 Transparency is increasing, revealing the serious problem of patent system abuse, which is breaking down the cultural notion that the patent system is sacrosanct.

Challenges and Optimism for Change

• 🚧 The pharmaceutical industry and its lobbyists have immense influence over the patent office and political processes.
• 📈 Despite challenges, progress is being made, with Congress acting on patent issues and showing increased awareness.
• 🌱 While change is not happening quickly, there is optimism that continued exposure of the system's abuses will force further action and reform, addressing the root cause of high drug prices which lies in how companies use the patent system.